← Back to Search

Mobile App Therapy for Post-Critical Illness Distress

N/A

Recruiting

Led By Nadia Liyanage-Don, MD, MS

Research Sponsored by Columbia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 12 weeks

Awards & highlights

Study Summary

This trial aims to test if a new app can help reduce distress in people who were hospitalized with a critical illness. They will use the app to process distressing memories & answer questionnaires to measure the effect.

Who is the study for?

This trial is for English-speaking adults who were in the ICU over a month ago and are feeling distressed about that experience. They need to have internet, a smartphone, and score at least 10 points on a distress scale (PCL-5). People with cognitive impairments, substance abuse issues, severe mental illness, or those unable to follow up due to terminal illness or travel can't join.Check my eligibility

What is being tested?

The study tests an app designed to help users process difficult memories from their ICU stay. Participants will use this app for six weeks, three times weekly for at least 30 minutes each session. The aim is to see if it's feasible for patients post-ICU to use the app and if it helps reduce their distress.See study design

What are the potential side effects?

Since this intervention involves using an app rather than medication or medical procedures, traditional side effects aren't expected. However, participants may experience emotional discomfort while processing distressing memories.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Mean duration of time spent using the Memory Processing module

Mean number of times that the Memory Processing module is accessed

Proportion of eligible participants who enroll in the study

+6 more

Secondary outcome measures

Anxiety Sensitivity Index (ASI) score

Frequency of sleep medication use

Generalized Anxiety Disorder Scale (GAD-7) score

+5 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Messy Memories InterventionExperimental Treatment1 Intervention

All participants enrolled in the study will be assigned to the experimental arm and participate in the Messy Memories intervention.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor

1,433 Previous Clinical Trials

2,447,229 Total Patients Enrolled

5 Trials studying Health Behaviors

671 Patients Enrolled for Health Behaviors

National Institute on Aging (NIA)NIH

1,675 Previous Clinical Trials

28,020,855 Total Patients Enrolled

13 Trials studying Health Behaviors

350,348 Patients Enrolled for Health Behaviors

Ian Kronish, MD, MPHStudy DirectorColumbia University

2 Previous Clinical Trials

25 Total Patients Enrolled

1 Trials studying Health Behaviors

15 Patients Enrolled for Health Behaviors

Media Library

Messy Memories Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05849454 — N/A

Health Behaviors Research Study Groups: Messy Memories Intervention

Health Behaviors Clinical Trial 2023: Messy Memories Intervention Highlights & Side Effects. Trial Name: NCT05849454 — N/A

Messy Memories Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05849454 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings available in this clinical research project?

"The records found on clinicaltrials.gov show that this study is not recruiting participants, despite being posted on the 1st of May 2023 and last edited 28th April. However, there are 296 other trials currently open to patients at present."

Answered by AI

What is the primary aim of this experiment?

"The primary outcome of this trial, to be measured prior to intervention, is the Proportion of eligible participants who enrol in the study. Secondary objectives include assessing depression levels using the Patient Health Questionnaire (PHQ-8) score (scores ≥10 being considered positive for depression), Generalized Anxiety Disorder Scale (GAD-7) score (scores ≥ 10 indicating greater anxiety), and Anxiety Sensitivity Index (ASI) scores with a cut-point score of 17 or higher deemed as having heightened sensitivity towards anxiousness."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Messy Memories: Mobile Application Therapy Following Critical Illness

Nadia A. Liyanage-Don 2023. "Messy Memories: Mobile Application Therapy Following Critical Illness". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05849454.